Project Grant HT94252410559
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$751K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23284, USA
Similar Awards
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $249,732 in funding to Virginia Commonwealth University (VCU) for research on novel kappa opioid receptor (KOR) agonists and their potential to promote central nervous system (CNS) repair. The award, which runs from September 1, 2024 to August 31, 2025, will enable VCU to conduct research aimed at developing effective treatments for...
This Project Grant from the Defense Health Agency provides $745,381 to Virginia Commonwealth University from June 1, 2023 through May 31, 2026 to support research on "POST-TRAUMATIC EPILEPTOGENESIS: ROLE OF NEOCORTICAL-HIPPOCAMPAL INTERACTIONS" under the Military Medical Research and Development program (CFDA 12.420). VCU will conduct this research to advance the program's goals of transforming military and public healthcare through innovative biomedical research solutions. Subawards...
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
This $5,954,349.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a randomized controlled trial to optimize heart rate variability treatment for combat veterans and service members with persistent post-concussion symptoms. The prime awardee, Virginia Commonwealth University, is collaborating with two sub-awardees, the Palo Alto Veterans Institute for Research and the Richmond Institute for Veterans Research,...
Virginia Commonwealth University was awarded a two-year, $232,875 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "GLT-1/EAAT2: A NOVEL PLAYER IN MYELIN REPAIR" being conducted between September 30, 2022 and September 29, 2024 in Richmond, Virginia. Through this funding, VCU researchers will investigate medical solutions for the battlefield by exploring the...
The Virginia Commonwealth University will receive $1.5 million over four years from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to manage distress in malignant brain cancer. Through this Project Grant award issued on August 1, 2021 and concluding on July 31, 2025, VCU will provide services to transform healthcare for service members and the public through innovative research investigating medical solutions for the...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $378,260.00 in funding to Virginia Commonwealth University (VCU) from February 1, 2024 to January 31, 2026 for the project "GENE THERAPY IN EXPERIMENTAL HYDROCEPHALUS." The award supports VCU's biomedical research on developing gene therapy treatments for hydrocephalus, a condition involving abnormal accumulation of cerebrospinal fluid in the brain....
This federal Project Grant award, valued at $977,826.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award will support research by Virginia Polytechnic Institute & State University (Virginia Tech) on the role of traumatic brain injury in the progression of Parkinson's disease. The research project will be conducted over a 3-year period from April 2025 to April 2028. Virginia Tech, a leading public research...